Ramaswamy Subramanian
About Ramaswamy Subramanian
Data last updated:
Ramaswamy Subramanian is a Director at Centre For Cellular And Molecular Platforms (since 2010), Director at Eyestem Research Private Limited (since 2020) and Director at Ultranutri India Private Limited (since 2025). The companies operate in Professional Services, Research & Development and FMCG. The 3 current companies with reported revenue have a combined latest revenue of ₹30.94 Cr; the largest is Centre For Cellular And Molecular Platforms at ₹28.51 Cr (FY 2025). Earlier, Ramaswamy Subramanian was a Director at Aiyon Products Private Limited (2019–2025) and Director at Aiyon Innovations Private Limited (2021–2023) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Centre For Cellular And Molecular Platforms U73200KA2010NPL052117 | Director | 19 Mar 2010 | 2010 | ₹28.51 Cr (FY 2025) | Active |
 Eyestem Research Private Limited U74999KA2015PTC164505 | Director | 13 Jan 2020 | 2015 | ₹2.13 Cr (FY 2025) | Active |
 Ultranutri India Private Limited U73200KA2021PTC153649 | Director | 27 May 2025 | 2021 | ₹29.9 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Aiyon Products Private Limited U36990KA2019PTC120761 | Director | 03 Jun 2019 | 2019 | Strike Off | |
| Aiyon Innovations Private Limited U74999KA2017PTC109050 | Director | 02 Nov 2021 | 2017 | Strike Off | |
| Indian Health Systems Private Limited U85110KA2007PTC044633 | Director | 07 Oct 2013 | 2007 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ramaswamy Subramanian
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ramaswamy Subramanian
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ramaswamy Subramanian
Ramaswamy Subramanian currently holds 3 directorships: Centre For Cellular And Molecular Platforms (Director, since 19 Mar 2010, revenue ₹28.51 Cr (FY 2025)); Eyestem Research Private Limited (Director, since 13 Jan 2020, revenue ₹2.13 Cr (FY 2025)); Ultranutri India Private Limited (Director, since 27 May 2025, revenue ₹29.9 Lakh (FY 2025)).
Ramaswamy Subramanian was first appointed on 19 Mar 2010 as Director at Centre For Cellular And Molecular Platforms. The most recent appointment on record is 27 May 2025 at Ultranutri India Private Limited.
The 3 current companies of Ramaswamy Subramanian that report revenue have a combined latest revenue of ₹30.94 Cr: Centre For Cellular And Molecular Platforms ₹28.51 Cr (FY 2025); Eyestem Research Private Limited ₹2.13 Cr (FY 2025); Ultranutri India Private Limited ₹29.9 Lakh (FY 2025).
Ramaswamy Subramanian held 3 earlier board appointments: Aiyon Products Private Limited (Director, 03 Jun 2019 to 21 Feb 2025); Aiyon Innovations Private Limited (Director, 02 Nov 2021 to 28 Mar 2023); Indian Health Systems Private Limited (Director, 07 Oct 2013 to 01 Mar 2018).
The current boards of Ramaswamy Subramanian's companies include Manoj Kumar (Centre For Cellular And Molecular Platforms), Satyajit Satyapal Mayor (Centre For Cellular And Molecular Platforms), Shashidhara Subrahmanya Lingadahalli (Centre For Cellular And Molecular Platforms), Shrikumar Suryanarayan (Centre For Cellular And Molecular Platforms), Taslimarif Turabmiya Saiyed (Centre For Cellular And Molecular Platforms), Taslimarif Turabmiya Saiyed (Centre For Cellular And Molecular Platforms), among others.